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Objectives: To compare the diagnostic usefulness in tuberculosis of the serodiagnostic enzyme-linked immunosorbent 
assay (ELISA) kit A60 (Anda Biologicals, Strasbourg, France) and of our domestic ELSA based on three purified cell wall 
glycolipid antigens. 
Methods: The presence and concentrations of IgG and IgM anti-A60 antibodies and anti-LOS, anti-DAT and anti-PGLTbl 
antibodies against the glycolipid antigens were determined by ELSA in 50 HIV-seronegative and 46 HIV-seropositive 
patients, with documented active tuberculosis. The specificity of these ELlSAs was determined with use of sera from 50 
healthy blood donors, 29 patients with non-mycobacterial pulmonary diseases and 24 HIV-positive patients with 
disseminated Mycobacterium aviurn infection. 
Results: With a calculated cut-off for each antigen and immunoglobulin that gave a specificity higher than or equal to 
98%, the cumulative ELSA results showed that only 36.5% of the patients with tuberculosis had a positive response in 
the A60 test, as compared with 84.4% who showed a response to the three glycolipid antigens (pc0.001). This striking 
difference persisted when the cumulative sensitivities were calculated according to the HIV status of the patients and 
the localization of tuberculosis. The anti-A60 antibody (IgG and IgM) levels and the degree of sensitivity of the ELISA for 
detection of A60 antigen were always lower in HIV-positive patients with pulmonary and extrapulmonary tuberculosis 
than in HIV-negative patients with tuberculosis. The sensitivity of A60 ELISA was further decreased in HIV-positive 
patients with low CD4' lymphocytes counts, in contrast to the results with the three glycolipid antigens. 
Conclusions: These results show the limitations of the A60 ELISA, and confirm the potencies of the glycolipid antigens 
in serodiagnosis of tuberculosis in HIV-positive and HIV-negative patients. 
Key words: A60 antigen, glycolipid antigens, pulmonary and extrapulmonary tuberculosis, HIV seronegative and 
seropositive, CD4+ lymphocytes, Ziehl-Neelsen smear test 
INTRODUCTION 
Human tuberculosis remains a common disease in 
developing countries. In Europe and the USA its 
incidence had decreased during the last decade, but is 
now rising following the emergence of AIDS 111, the 
deterioration of control measures and the increase in 
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untested immigrants [2]. It is estimated that more than 
three million people worldwide are infected with both 
Mycobacterium tuberculosis and HIV [3]. Among the 
diseases associated with HIV infection, tuberculosis 
(TB) is of particular importance. It is often the first 
clinical madestation of immunodeficiency, it is highly 
transmissible and it is associated with rapid deterio- 
ration of the immune competence of the host. How- 
ever TB is potentially preventable by chemoprophylaxis 
and is readily treatable [4]. Screening for TB at HIV 
testing sites could be an effective approach to early 
detection of active TB not just among HIV-positive, 
but also in HIV-negative, inhviduals [5]. However, 
the discriminative values of the tuberculin slun test 
vary with the population tested, and hrthermore the 
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reaction to purified protein derivate cannot be read 
before 48 to 72 h and the required return visit would 
make the process of TB screening cumbersome. 
As an alternative, several immunologic methods 
have been used to detect serum antibodies against 
mycobacterial antigens in TB patients [6]. The 
enzyme-linked immunosorbent assay (ELISA) has been 
widely used for the diagnosis of active TB [7], and can 
evaluate the response in different immunoglobulin 
classes, IgG being the most mscriminatory when TB 
patients are compared with healthy control subjects 
[8,9]. During the last 15 years several purified antigens 
fiom M.  tuberculosis have been used for the serodiagnosis 
of tuberculosis [lo]. They include a high-molecular- 
weight mycobacterial antigen complex, known as 
A60 [l l] .  The detection of immunoglobulin G (IgG) 
antibodies to A60 has been advocated as a reasonably 
sensitive and specific test for active tuberculosis [12]. It 
is the only commercially available ELISA test for the 
diagnosis of tuberculosis in France. However, there are 
contradictory reports about the usefulness of A60 
ELISA in HIV-positive patients [13]. The aim of this 
study was to compare the discriminative values of an 
ELISA test using A60 with those obtained with a 
domestic ELISA test, whch has already been described 
[9,14], using three glycolipid antigens specific for M. 
tuberculosis. These were applied to the same serum 
specimens taken from HIV-negative and HIV-positive 
patients with documented (culture-positive) tuber- 
culosis before they received any treatment. 
PATIENTS AND METHODS 
Study population 
Mycobacterial diseases 
Between May 1991 and May 1994, acid-fast bacteria 
were isolated fiom 120 hospitalized patients (aged 21 to 
85 years) and identified by procedures recommended 
by reference laboratories. Of these patients, 96 were 
infected with M. tuberculosis and 24 with mycobacteria 
other than tuberculosis (MOTT), mostly M.  avium- 
intracellulare. Among the 96 patients with documented 
tuberculosis, 22 were female and 74 were male. 
Forty-six patients with tuberculosis had a pulmonary 
localization (21 HIV positive and 25 HIV negative), 
and 50 had extrapulmonary tuberculosis (25 HIV 
positive and 25 HIV negative). Among the 25 HIV- 
negative patients with extrapulmonary dsease, the 
localizations of tuberculosis were lymphatic tissues (12), 
pleural effusion (4), bone (3), gastrointestinal tract 
(2), disseminated tuberculosis (2), central nervous 
system (1) and skin (1). Among the 25 HIV-positive 
patients, 15 patients had disseminated tuberculosis, 9 
had lymph node involvement, and one had a pleural 
effusion. The mean ages were slmilar in the different 
subgroups (39.2 2 2.2 versus 36.6 k 1.9 in HIV-positive 
patients with extrapulmonary tuberculosis and pul- 
monary tuberculosis, and 43.9 k 3.3 versus 40.9 C 2.5 
in HIV-negative patients with extrapulmonary and 
pulmonary tuberculosis, respectively). CD4+ T lympho- 
cyte counts were known in 38 HIV-positive patients 
within 3 months of the time of diagnosis of tuber- 
culosis and there was no statistically significant dif- 
ference for the mean f SEM of CD4+ lymphocytes 
between patients with pulmonary (89.9 f 22.9) and 
patients with extrapulmonary TB (88.3 k 20.5). 
The median CD4+ T-lymphocyte counts were also 
equivalent (50 CD4+/mm3 and 47 CD4+/mm3, 
respectively). AU the MOTT-infected patients were 
HIV positive and presented disseminated atypical 
mycobacterial mseases. 
Control subjects 
Sera from 50 healthy blood donors and fiom 29 patients 
with pulmonary diseases but without documented 
mycobacterial isolation (12 being HIV negative and 
17 being HIV positive) were used as normal and 
pathologic controls, respectively. AU sera were collected 
fiom patients in the TB-HIV-, TB-HIV+ and other 
mycobacteriosis groups, on the day when specimens 
were obtained for the bacteriologic diagnosis of 
mycobacteriosis. AU sera were conserved at -20°C 
until tested. 
Antigens 
The isolation, purification and characterization of the 
LOS (fractions 4 and 5 of polar glycolipids belonging 
to the lipo-oligosaccharide family), DAT (2,3- 
diacyltrehalose, formerly referred to as SL IV antigen), 
and PGLTbl (triglycosyl phenol phthocerol dimyco- 
cerosate) were carried out as previously reported 
[15-181. The three glycolipid antigens used in our 
ELISA test were kindly supplied by Dr E Papa (Unit6 
de Tuberculose et Mycobacteries, Institut Pasteur, 
Paris, France). A60 is a commercialy available enzyme- 
linked immunosorbent assay (ELISA, Anda Biological, 
Strasbourg, France). 
Enzyme immunoassa y procedure 
The glycolipid ELSA test was performed in poly- 
styrene microtiter plates from Costar (France), by a 
previously described method with some modifications 
that have already been published [14]. At the same time, 
IgM and IgG against A60 were determined in an 
ELISA test, according to the manufacturer’s instruc- 
tions. Final calculations were performed as already 
described by Cruaud et al. [ 191. 
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Statistical analysis 
Arithmetic mean, median and standard error of the 
mean (SEM) were calculated for optical density values. 
Statistical sigruficance was determined using the Quattro 
Pro 5.0 program (Borland, France). The significance of 
differences between continuous, normally distributed 
variables was calculated using the Student’s t-test. Sen- 
sitivity, specificity and predictive values were estimated 
as recommended [20,21]. Frequencies were compared 
using the chi-squared test with Yates and Bonferroni 
corrections [22]. 
RESULTS 
Cut-off points for the sensitivity and specificity of the 
ELISA with each antigen and immunoglobulin were 
calculated from the results obtained with sera from 
healthy blood donors and the pathologic control groups 
(including sera from HIV patients with disseminated 
MOTT disease). Among the 96 documented tuber- 
culosis patients, 81 were positive for at least one antigen 
in ELISA with LOS, DAT or PGLTbl (IgG antibody 
determination) in comparison with only 35 that were 
positive in A60 antigen tests when IgG and IgM 
antibody estimations were combined. 
Antibody levels to AW, LOS, DAT and PGLTb1 antigens 
The individual levels of IgG antibodies to LOS, DAT 
and PGLTbl antigens and of IgG and IgM antibodies 
to A60 antigens in patients with documented tuber- 
culosis, in healthy people and in pathologic controls are 
shown in Figures 1 and 2. In general, antibody titers 
were hgher in tuberculosis patients than in healthy and 
pathologic controls (p<O.OOl). There were very few 
false positive reactions among healthy donors and 
pathologic controls. However, approximately one-third 
of false-negative results were obtained with the three 
glycolipid antigen ELISA, and rather more than half 
when A60 ELSA was used, in patients with tuber- 
culosis. 
The means of specific antibody levels to each 
antigen (LOS, DAT, PGLTbl and A60) were calculated 
in subgroups of HIV-negative and HIV-positive patients 
with tuberculosis, according to the localization of 
disease and to the smear test results. The mean values 
and standard errors of the mean of optical densities 
(ODs) obtained with the sera from 46 HIV-positive and 
50 HIV-negative TB patients are shown in Table 1. In 
general, there was no statistically significant difference 
between the antibody levels in multibacillary (smear 
positive) TB and in paucibacillary (smear-negative) TB 
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Figure 1 Individual serum levels of IgG antibody to LOS (A), DAT (B) and PGLTbl (C) from Mycobacterium tuberculoris in 
the sera of 96 tuberculosis patients (l), 29 pulmonary duease controls (2) and 50 healthy blood donors (3). The cut-off 
points between positive and negative tests are indicated by the broken horizontal lines. 
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Figure 2 Individual serum levels of Igh4 (A) and IgG (B) antibody to A60 antigen from the same groups as indicated in 
Figure 1 
except for the PGLTbl and A60 antigens in HIV- 
negative TB patients. These HIV-negative patients 
with multibacillary TB had significantly lower levels 
( p <  0.05) of anti-PGLTbl antibody than HIV-negative 
patients with paucibacillary TB. The reverse was 
observed when levels of anti-A60 (IgG or IgM) 
antibodies were considered; however, only the HIV- 
negative patients with multibacillary TB had signifi- 
cantly higher levels of IgM anti-A60 antibody as 
compared with the HIV-negative patients with pauci- 
bacillary TB. 
Sensitivities of the different antigens 
The sensitivities of the ELISAs using the IgG assays for 
the three glycolipid antigens were compared with the 
sensitivities of the ELISA using the IgM and IgG assays 
for the A60 antigen in the 96 patients with documented 
tuberculosis, independently of their HIV status (Table 
2). The results showed that A60 ELISA for IgG or for 
IgM antibodies was always less sensitive (28.1% and 
17.7%, respectively) than the glycolipid ELISA for IgG 
(anti-LOS, 64.6%; anti-DAT, 61.5%; anti-PGLTb1, 
54.2%). A sample was considered positive if a positive 
response to at least one of the three glycolipid antigens 
or to at least one of the IgG and IgM determination for 
A60 was detected. The cumulative sensitivity of two 
combined tests was always higher (p<O.Ol) when two 
glycolipid antigens were used, than when IgG and IgM 
A60 tests were combined (Table 2 ) .  The higher 
cumulative sensitivity was due to the fact that some 
patient sera reacted with only one antigen, while some 
react with all three glycolipid antigens. The cumulative 
sensitivity was further increased when the sensitivity 
was calculated using the combined results of the three 
glycolipid antigens, reaching 84.4% ( p <  0.05). 
Only one serum sample from a healthy blood 
donor was positive for DAT and PGLTbl. The 
specificities calculated from the results in healthy 
controls were 98% for DAT and PGLTbl and 100% for 
LOS and A60 IgG and IgM. Such high specificity 
(98%) remained when the results of the three antigens 
(LOS, DAT, PGLTbl) or those of IgM and IgG ELISA 
A60 were combined (Table 3 ) .  When ELSA for 
the three glycolipid antigens was considered, high 
specificity (100%) was observed in pulmonary disease 
HIV-negative controls, but it dropped to 82.4% in the 
HIV-positive pulmonary disease controls and was 
further diminished to 62.5% in HIV-positive patients 
with disseminated atypical mycobacteriosis. Such 
reduced specificity was not observed when ELISA for 
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Table 1 Anti-LOS, anti-DAT, anti-PGLTbl IgG and anti-A60 IgG and IgM antibody levels according to smear positivity or 
negativity in HIV-negative and HIV-positive patients with pulmonary and extrapulmonary tuberculosis 
Optical density (mean k SEM)” 
HIV-negative patients HIV-positive patients 
Antigen Smear test Total Pulmonary Extrapulmonary Total Pulmonary Extrapulmonary 
LOS + 162.02 45.9 184.2255.5 91.0k74.9 152.5233.5 159.8f56.9 147.5k42.7 
103.3k15.7 96.3k26.8 104.2k19.6 171.7k22.6 167.0+ 28.9 176.4k36.1 
DAT + 270.2 f 5 1.6 312.7f64.2 134.4 2 20.7 217.4k27.5 269.7+ 50.4 181.2+ 28.2 
203.7227.9 156.1 f 47.6 225.2f33.9 280.8f30.8 250.6k30.7 311.0-153.4 
PGLTbl + 77.1 k 17.9 88.3k 22.7 41.4k 14.4 244.5328.7 299.3f73.4 206.5k41.6 
291.lf 58.5 
(D<0.001) (J-0.001) 
164.6 f34.0 125.2k39.3 182.6546.3 264.2k34.4 237.3k50.9 
A60.G + 533.7k136.8 535.6k151.3 527.62 344.1 355.5k94.6 255.3f 91.4 424.92 147.3 
391.4f75.9 461.12175.9 411.0k 115.6 231.6f69.7 290.32 136.1 172.9k34.5 
729.0 f 303.4 3263289.8 341.1+ 86.9 316.9f 142.8 A60.M + 727.9k110.6 726.6k116.9 
(~‘0.05) (p<O.Ol) 
237.4f 39.0 393.6567.9 468.0k 134.2 360.1 279.2 286.92432 336.4276.5 
~ _ _ _  ~ ~~~~ ~~~ ~ ~~~ ~ ~~~ 
’Absorbance at 414 nm X lo-’; k SEM (standard error of the mean). 
Table 2 Sensitivity of the ELISA for detection of anti-A60 IgG or IgM and of anti-LOS, anti-DAT and anti-PGLTbl IgG 
antibodies in various study groups 
Active tuberculosis Active tuberculosis HIV-negative Active tuberculosis HIV-positwe 
(n=96) ( ~ 5 0 )  ( ~ 4 6 )  
Percent Percent Percent 
Antigen No. positive sensitivity No. positive sensitivity No. positive sensitivity 
A60 (I&) 27 28.1 18 36.0 9 19.6 
A60 (W) 17 17.7 12 24.0 5 10.9 
DAl- (I&) 59 61.5 27 54.0 32 69.6 
PGLTbl (IgG) 52 54.2 16 32.0 36 78.3 
LOS (I&) 62 64.6 28 56.0 34 73.9 
A60 (IgG -k I@) 35 36.5 23 46.0 11 23.9 
DAT + LOS (I&) 77 80.2 37 74.0 40 86.9 
PGLTbl + LOS (I&) 74 77.1 34 68.0 40 86.9 
DAT + PGLTbl (I&) 69 71.9 31 62.2 38 82.6 
DAT + PGLTbl + LOS (IgG) 81 84.4 39 78.0 42 91.3 
Cut-off points: LOS, 65; DAT, 150; PGLTbl, 126; A60.G, 360; A60.M, 684. 
Table 3 Specificity of the ELISA for detection of A60 (IgG + IgM) and three glycolipid antigens (LOS + DAT + 
PGLTbl-IgG) in the various control groups 
A60 (IgG + IgM) LOS + DAT + PGLTbl (IgG) 
Study p u p  No of sera tested No. positive Percent specificity No. positive Percent specificity 
HIV negative 
Pulmonary disease 12 3 75.0 
Blood donors 50 0 100.0 
HIV positive 
Pulmonary disease 17 3 82.4 





Cut-offpoints: A60G. 360; A60M. 684; LOS, 65; DAT, 150; PGLTbl, 126. 
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A60 antigen was performed in these pathologic sera but 
was about 80% in HIV-positive or HIV-negative 
patients with locahzed or disseminated MOTT 
infection. 
Influence of clinical and biological parameters 
on ELISA sensitivity 
HIV immune status 
HIV-positive patients with tuberculosis had a statis- 
tically significantly greater response (p<0.05) to each of 
the glycolipid antigens in general (73.9% for LOS, 
69.6% for DAT and 78.3% for PGLTbl) than HIV- 
negative patients with tuberculosis (56%, 54% and 32% 
for LOS, DAT and PGLTbl, respectively)(Table 2). 
The opposite was observed when A60 antigen was used: 
the positive responses were always more numerous in 
HIV-negative patients with tuberculosis than in HIV- 
positive patients with tuberculosis. The A60 IgG 
determinations gave almost twice as many positive 
results as the A60 IgM determinations, but only one 
third of the HIV-positive patients responded to this 
antigen. When combined ELISA test results were 
analyzed, similar results were obtained. 
Extension and status of the disease 
Among the 96 TB patients, 46 had pulmonary and 50 
extrapulmonary tuberculosis; 43 (44.8%) were smear 
positive and 53 (55.2%) were smear negative. In the 
group of 50 HIV-negative tuberculosis patients, 64% 
of pulmonary tuberculosis cases were smear-positive, 
compared to only 20% of extrapulmonary cases 
(p<O.Ol), giving an overall sensitivity of the smear test 
of 42% for the HIV-negative patients. In contrast, there 
was no statistically significant difference for smear test 
sensitivity between pulmonary (42.9%) and extrapul- 
monary (52.0%) tuberculosis cases in the HIV-positive 
group of patients. In HIV-positive patients with active 
tuberculosis the ELISA sensitivities to the three 
glycolipid antigens were statistically significantly higher 
than the ELISA sensitivities to A60 and were influenced 
neither by the locahzation of tuberculosis nor by the 
smear test results. In the HIV-negative patients with 
tuberculosis, the differences were less pronounced but 
still statistically significant when tuberculosis localiza- 
tion was compared, but not when the smear test results 
were considered (Table 4). 
Number of circulating CD4' lymphocytes 
For all antigens except the LOS, the sensitivity of the 
ELISA was significantly higher in patients who had 100 
or more CD4' lymphocpes/mm3 (Table 5); there were 
more positive ELISA test results in patients who had 
less than 100 CD4 lymphocytes/mm3. When the 
results were stratified according to the localization of 
tuberculosis, the differences were only statistically 
significant in HIV-positive patients with extrapul- 
monary tuberculosis and not in patients with pul- 
monary tuberculosis. 
DISCUSSION 
The first important finding of this study was that the 
sensitivity of ELISA for anti-A60 IgG was statistically 
significantly lower (P<O.Ol) than the sensitivity of 
ELISA for IgG against LOS, DAT and PGLTbl in the 
96 patients with tuberculosis; 28.1% compared with 
64.6%, 61.5% and 54.2%, respectively, gave positive test 
results. The sensitivity of testing for anti-A60 IgM 
antibodies was even lower (17.7%) than the sensitivity 
obtained with the anti-A60 IgG antibody. The different 
combinations of the ELISA results obtained with each 
of the three glycolipid antigens and with the A60 IgG 
and IgM ELISA results were analyzed in order to 
increase the sensitivity while keeping the specificity 
high. The sensitivity of the ELISA increased when the 
results with LOS, DAT or PGLTbl were combined in 
pairs, and addition of test results obtained using the 
three glycolipid antigens hrther increased the 
sensitivity to 84.4%. The ELISA sensitivity in these 
patients increased in the same way when the results 
with anti-A60 IgG and anti-A6O IgM were combined, 
but the combined sensitivity reached only 36.5%. On 
the other hand, there was no increase in the false 
positive rate among the control subjects (Table 3). 
Similar findngs have already been reported for 
combining the results obtained with three glycolipids 
[23] or with glycolipids and antigen 5 [24]. 
Analysis of these results according to patient 
features confirmed the results of several recent studies 
[13,25,26]. The sensitivity of testing for anti-A60 (IgG, 
IgM) antibodes was statistically significantly lower 
@<0.0033) among HIV-positive than among HIV- 
negative patients with tuberculosis: 23.9% compared 
with 46% had positive ELISA results, respectively. 
Such differences persisted also when TB patients were 
stratified for 1ocaLzation of tuberculosis (Table 1). The 
false-negative results of the A60 ELISA in HIV-positive 
patients were directly related to the low numbers of 
circulating CD4+ lymphocytes (Table 5), as already 
reported by Saltini et al. [25]. However, the 46% 
estimate of the A60 ELISA sensitivity among HIV- 
negative patients reported here is lower than the 
sensitivities previously reported for HIV-uninfected 
patients with active TB [12,27-301. Among HIV- 
uninfected patients with non-TB pulmonary condi- 
tions, the detection of IgG and IgM against A60 
antigen complex has been reported to be 71-94% 
specific for active TB [12,27,28,30]. In this report, in 
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Table 4 Sensitivity of the ELISA for IgG anti-glycolipid (LOS, DAT, PGLTbl) antibodies and of IgG + IgM antibodies to 
A60 in the various study groups according to HIV serostatus, localization of disease and smear test results in patients with 
documented active tuberculosis 
ELISA No. of patients giving positive results (“9) 
HIV-positive patients (n=46) HIV-negative patients (n=50) 
LOS+DAT+PGLTbl 42 (91.3) 39 (78.0) 
A60 (IgG + IgM) 11 (23.9) 23 (46.0) 
p ~ 0 . 0 0 0 1  p<0.0001 
Pulmonary (n=21) Extrapulmonary (n=25) Pulmonary (n=25) Extrapulmonary (n=25) 
LOS+DAT+PGLTbl 20 (95.2) 22 (88) 20 (80) 19 (76) 
A60 (IgG + IgM) 6 (28.6) 5 (20) 11 (44) 12 (48) 
p<0.0001 p <0.0001 p <0.0003 p<0.005 
Smear + Smear - Smear + Smear - Smear + Smear - Smear + Smear - 
(n=9) (n=12) (n=13) (n=12) (n=16) (n=9) (n=5)  (n=20) 
~ ~~~~ 
LOS+DAT+PGLTbl 9 (100) 11 (91.6) 11 (84.6) 11 (91.6) 14 (87.5) 6 (66.7) 3 (60.0) 16 (80.0) 
A60 (IgG + IgM) 2 (22.2) 4 (33.3) 4 (30.8) 1 (8.3) 8 (50.0) 3 (33.3) 4 (80.0) 8 (40.0) 
~ ~ ~~~~~ 
Cut-off points: LOS, 65; DAT, 150; PGLTbl, 126; A60 IgG, 360; A60 IgM, 684. 
order to adjust the two ELISA tests for comparable 
specificity using the results from healthy donors, higher 
cut-off values were needed, which consequently 
reduced sensitivity. In contrast, and as already described 
by Martin-Casabona et al. [31], and in a previous report 
[9], the sensitivity of testing for anti-LOS, anti-DAT 
and anti-PGLTbl IgG antibodies was statistically 
higher (p<0.0304) among HIV-positive than among 
HIV-negative patients with tuberculosis: 91.3% and 
78%, respectively, had positive test results. No 
statistically significant differences were found in the 
antibody levels to the three glycolipid antigens in 
relation to the localization of TB (Table 1). Moreover, 
no difference was found in the combined ELISA results 
in relation to the direct microscopy results in HIV- 
positive or HIV-negative patients with pulmonary or 
extrapulmonary tuberculosis. 
Table 5 ELISA test results in 38 HIV-positive patients with 
documented tuberculosis according to their circulating 
CD4+ lymphocytes 
Number of positive/negative results 
Number of CD4+ lymphocytes/mm’ 
Antigens 

















Cut-off points: LOS, 65; DAT, 150; PGLTbl, 126; A60 IgG, 360; 
A60 IgM, 684. 
A serodiagnostic test with a high specificity would 
justie the start of chemotherapy in suspected tuber- 
culosis before culture results were available. The pre- 
valence of TB in hospital populations suspected of 
having TB has been reported to be 30-52% [28,32,33]. 
However, as already reported by Daniel et al. [34], in a 
group of hospitalized subjects requiring investigation 
for tuberculosis in a university hospital such as ours the 
prevalence of tuberculosis would probably be closer to 
15%. Assuming a prevalence of 15%, the positive and 
negative predictive values of the LOS, DAT and 
PGLTbl antigens, using the cut-off values determined 
with the results obtained with the blood donors, were 
88.2%, and 97.3%, respectively, when the HIV status 
was not considered. When the cut-off values were 
obtained in the HIV-negative pathologic controls, the 
predictive values were higher (PPV=lOO%; NPV= 
96.3%). But the positive predictive value dropped to 
47.9%, for a negative predictive value of 98.2%, if cut- 
off values were obtained in the HIV-positive controls 
with non-TB pulmonary conditions. The HIV-positive 
control group included patients with disseminated 
mycobacterial infections other than TB. Knowing 
that the specific glycolipid antigens did not cross-react 
with antisera induced by M.  avium infection [35] 
and since antibody titers were also lower in such 
HIV-positive controls than in active TB patients, it 
is quite possible that such low persisting antibodies 
in HIV-positive controls reflect either non-active 
TB which had been treated several months before 
these episodes, or concomitant infection with M.  tuber- 
rdosis and M .  avium [36]. This possibility is being 
investigated. 
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The positive predictive values of the A60 ELISA 
(from 18.4% to 24.6%) become too low to be clinically 
useful in HIV-positive or in HIV-negative patients 
suspected to have tuberculosis. In contrast, the optimal 
sensitivity and specificity were obtained by combining 
the results of the ELISA with the LOS, DAT and 
PGLTbl antigens. Such an ELISA assay may be 
clinically useful in patients clinically suspected to have 
TB. 
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